at least 1 year in patients following an
acute coronary syndrome. Evidence
supports use of either ticagrelor or clopidogrel
if no percutaneous coronary
intervention (PCI) was performed and
the use of clopidogrel, ticagrelor, or
prasugrel if PCI was performed